These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 674234
1. Role of manganese, bilirubin and sulfobromophthalein in manganese-bilirubin cholestasis in rats. Lamirande ED, Plaa GL. Proc Soc Exp Biol Med; 1978 Jun; 158(2):283-7. PubMed ID: 674234 [No Abstract] [Full Text] [Related]
2. Bilirubin excretion pattern in manganese-bilirubin cholestasis. de Lamirande E, Plaa GL. Arch Int Pharmacodyn Ther; 1979 May; 239(1):24-35. PubMed ID: 485717 [Abstract] [Full Text] [Related]
3. Bilirubin as a cholestatic agent. IV. Effect of bilirubin and sulfobromophthalein (BSP) on biliary manganese excretion. Witzleben CL, Boyce WH. Arch Pathol; 1975 Sep; 99(9):496-8. PubMed ID: 1164253 [Abstract] [Full Text] [Related]
4. Bilirubin as a cholestatic agent. III. Prevention of bilirubin-related cholestasis by sulfobromophthalein. Witzleben CL, Boyce WH. Arch Pathol; 1975 Sep; 99(9):492-5. PubMed ID: 1164252 [Abstract] [Full Text] [Related]
5. Morphological aspects of manganese-bilirubin induced cholestasis. de Lamirande E, Tuchweber B, Plaa GL. Liver; 1982 Mar; 2(1):22-7. PubMed ID: 7176835 [Abstract] [Full Text] [Related]
6. Hepatic subcellular distribution of manganese in manganese and manganese-bilirubin induced cholestasis. Ayotte P, Plaa GL. Biochem Pharmacol; 1985 Nov 01; 34(21):3857-65. PubMed ID: 4062960 [Abstract] [Full Text] [Related]
7. Dose and time relationships in manganese-bilirubin cholestasis. de Lamirande E, Plaa GL. Toxicol Appl Pharmacol; 1979 Jun 30; 49(2):257-63. PubMed ID: 494277 [No Abstract] [Full Text] [Related]
8. Effect of inhibition of protein synthesis on cholestasis induced by taurolithocholate, lithocholate, and a manganese-bilirubin combination in the rat. Dahlström-King L, Plaa GL. Biochem Pharmacol; 1989 Aug 01; 38(15):2543-9. PubMed ID: 2757652 [Abstract] [Full Text] [Related]
9. Hepatocellular membrane alteration as a possible cause of manganese-bilirubin-induced cholestasis. de Lamirande E, Tuchweber B, Plaa GL. Biochem Pharmacol; 1981 Aug 15; 30(16):2305-12. PubMed ID: 6457605 [No Abstract] [Full Text] [Related]
10. Functional changes of the biliary tree associated with experimentally induced cholestasis: sulfobromophthalein on manganese-bilirubin combinations. Dahlström-King L, Couture J, Plaa GL. Toxicol Appl Pharmacol; 1991 May 15; 108(3):559-67. PubMed ID: 1902335 [Abstract] [Full Text] [Related]
11. Liver cell plasma membrane lipids in manganese-bilirubin-induced intrahepatic cholestasis. Plaa GL, de Lamirande E, Lewittes M, Yousef IM. Biochem Pharmacol; 1982 Nov 15; 31(22):3698-701. PubMed ID: 7181957 [No Abstract] [Full Text] [Related]
12. Maximal biliary excretion of bilirubin and sulfobromophthalein during various rates of infusion in rats of different weights and strains. Klaassen CE, Roberts RJ, Plaa GL. Toxicol Appl Pharmacol; 1969 Jul 15; 15(1):143-51. PubMed ID: 5808207 [No Abstract] [Full Text] [Related]
13. The road to elucidating the mechanism of manganese-bilirubin-induced cholestasis. Goering PL. Toxicol Sci; 2003 Jun 15; 73(2):216-9. PubMed ID: 12778929 [No Abstract] [Full Text] [Related]
14. Bilirubin, bromsulphthalein and indocyanine green excretion in bile. Hargreaves T. Q J Exp Physiol Cogn Med Sci; 1966 Jul 15; 51(3):184-95. PubMed ID: 5182348 [No Abstract] [Full Text] [Related]
15. The effects of bromosulphophthalein, indocyanine green and bilirubin on the biliary excretion of methylmercury. Magos L, Clarkson TW, Allen J, Snowden R. Chem Biol Interact; 1979 Aug 15; 26(3):317-20. PubMed ID: 509694 [Abstract] [Full Text] [Related]
16. Effect of organic anions on bile acid uptake by isolated rat hepatocytes. Anwer MS, Hegner D. Hoppe Seylers Z Physiol Chem; 1978 Aug 15; 359(8):1027-30. PubMed ID: 711149 [No Abstract] [Full Text] [Related]
17. The sulfhydryl groups responsible for bilitranslocase transport activity respond to the interaction of the carrier with bilirubin and functional analogues. Passamonti S, Sottocasa GL. Biochim Biophys Acta; 1990 Jan 15; 1021(1):9-12. PubMed ID: 2294965 [Abstract] [Full Text] [Related]
18. [Preferential bile excretion among rifomycin SV, bilirubin and B.S.P]. Smets P. Rev Int Hepatol; 1968 Jan 15; 18(1):41-54. PubMed ID: 5678584 [No Abstract] [Full Text] [Related]
19. [The behavior of bilirubinemia after sulfobromophthalein loading]. Pippi L, Toti M, Bianchi GP, Marchi B. Quad Sclavo Diagn; 1973 Jun 15; 9(2):681-97. PubMed ID: 4789473 [No Abstract] [Full Text] [Related]
20. Alteration of lipid composition of hepatic membranes associated with manganese-bilirubin induced cholestasis. Duguay A, Yousef IM, Tuchweber B, Plaa GL. Fundam Clin Pharmacol; 1998 Jun 15; 12(2):213-9. PubMed ID: 9565777 [Abstract] [Full Text] [Related] Page: [Next] [New Search]